Ströhle Alexander
Med Monatsschr Pharm. 2011 Aug;34(8):291-8.
In the context of optimization long-term health, the research activities on the secosteroid vitamin D have become an important field of discourse. The discussion has focused on whether and, if so, to what extent, vitamin D might contribute to the prevention of various disorders, e.g. infections, autoimmune diseases, several types of cancer and diabetes mellitus type 2. Accordingly, in the recent past many voices were raised asking for a significant elevation of the recommended vitamin D intake. In November 2010 the decisive US Food and Nutrition Board (FNB) of the Institute of Medicine (IOM) revised the dietary reference intake for vitamin D. The updated recommendations were awaited eagerly and have now been published. This article discusses the new recommendation and comments on aspects which have to be considered critically.
在优化长期健康的背景下，关于维生素D（一种甾醇类维生素）的研究活动已成为一个重要的讨论领域。讨论聚焦于维生素D是否以及在何种程度上可能有助于预防各种疾病，如感染、自身免疫性疾病、几种类型的癌症和2型糖尿病。因此，最近有许多声音呼吁大幅提高维生素D的推荐摄入量。2010年11月，美国医学研究所（IOM）具有决定性作用的食品与营养委员会（FNB）修订了维生素D的膳食参考摄入量。人们急切期待着更新后的建议，现在这些建议已经发布。本文将讨论新的建议，并对一些必须审慎考虑的方面进行评论。
